Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
News|Articles|November 2, 2001
- Pharmaceutical Technology-11-02-2001
- Volume 25
- Issue 11
Outsourcing Outlook
Author(s)Jim Miller
The 2001 POMA Sourcing Survey declares 2001 a good year for drug development and manufacturing outsourcing.
Advertisement
Articles in this issue
almost 25 years ago
blankalmost 25 years ago
Truth in Outsourcingalmost 25 years ago
Manufacturers Face Challenges and Regulatory Changesalmost 25 years ago
One-Step Aqueous Enteric Coating Systems: Scale-Up Evaluationalmost 25 years ago
Filter Integrity Testing in Liquid Applications, Revisited Part IIAdvertisement
Related to this article
Shilpa Pharma Lifesciences Limited will launch a new small-molecule CDMO at CPHI Milan in October.
This article explains the 4 shifts enabling faster, lower-risk, commercially successful biologics technology transfer.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
2
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
3
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
4
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
5